Voyager Therapeutics Inc (VYGR)
8.81
+0.28
(+3.28%)
USD |
NASDAQ |
May 03, 16:00
8.81
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Max Drawdown (5Y): 92.11% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 92.11% |
| March 31, 2024 | 92.11% |
| February 29, 2024 | 92.11% |
| January 31, 2024 | 92.11% |
| December 31, 2023 | 92.11% |
| November 30, 2023 | 92.11% |
| October 31, 2023 | 92.11% |
| September 30, 2023 | 92.11% |
| August 31, 2023 | 92.11% |
| July 31, 2023 | 92.11% |
| June 30, 2023 | 92.11% |
| May 31, 2023 | 92.11% |
| April 30, 2023 | 92.11% |
| March 31, 2023 | 92.11% |
| February 28, 2023 | 92.11% |
| January 31, 2023 | 92.11% |
| December 31, 2022 | 92.11% |
| November 30, 2022 | 92.11% |
| October 31, 2022 | 92.11% |
| September 30, 2022 | 92.11% |
| August 31, 2022 | 92.11% |
| July 31, 2022 | 92.11% |
| June 30, 2022 | 92.11% |
| May 31, 2022 | 92.11% |
| April 30, 2022 | 92.11% |
| Date | Value |
|---|---|
| March 31, 2022 | 92.11% |
| February 28, 2022 | 92.11% |
| January 31, 2022 | 92.11% |
| December 31, 2021 | 92.11% |
| November 30, 2021 | 92.11% |
| October 31, 2021 | 92.11% |
| September 30, 2021 | 91.60% |
| August 31, 2021 | 90.96% |
| July 31, 2021 | 90.16% |
| June 30, 2021 | 87.42% |
| May 31, 2021 | 87.42% |
| April 30, 2021 | 85.72% |
| March 31, 2021 | 85.28% |
| February 28, 2021 | 81.89% |
| January 31, 2021 | 78.28% |
| December 31, 2020 | 78.28% |
| November 30, 2020 | 78.28% |
| October 31, 2020 | 78.28% |
| September 30, 2020 | 78.28% |
| August 31, 2020 | 78.28% |
| July 31, 2020 | 78.28% |
| June 30, 2020 | 78.28% |
| May 31, 2020 | 78.28% |
| April 30, 2020 | 78.28% |
| March 31, 2020 | 78.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
74.45%
Minimum
May 2019
92.11%
Maximum
Oct 2021
86.02%
Average
92.11%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Ligand Pharmaceuticals Inc | 77.41% |
| United Therapeutics Corp | 60.30% |
| MEI Pharma Inc | 95.76% |
| Agios Pharmaceuticals Inc | 82.86% |
| Macrogenics Inc | 93.69% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.01 |
| Beta (5Y) | 0.9834 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.05% |
| Historical Sharpe Ratio (5Y) | -0.2304 |
| Historical Sortino (5Y) | -0.6467 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.36% |